What is a good topical Non-Steroidal Anti-Inflammatory Drug (NSAID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical NSAIDs for Pain Management

Topical diclofenac gel is the most effective topical NSAID with a favorable safety profile and should be considered first-line for localized musculoskeletal pain. 1, 2, 3

Efficacy of Topical NSAIDs

Topical NSAIDs have demonstrated significant efficacy in treating localized pain, particularly in osteoarthritis and acute musculoskeletal conditions:

  • Diclofenac gel: Shows superior efficacy with an effect size of 0.91 and has the lowest NNT (Number Needed to Treat) of 1.8 for at least 50% pain reduction 2, 3
  • Ketoprofen gel: Demonstrates good efficacy with an NNT of 2.5 3
  • Ibuprofen gel: Shows moderate efficacy with an NNT of 3.9 3

The European League Against Rheumatism (EULAR) recommends topical NSAIDs as first-line pharmacological treatment for hand osteoarthritis due to their favorable safety profile compared to oral analgesics 1.

Advantages of Topical NSAIDs

  • Safety profile: Minimal systemic absorption leads to fewer systemic adverse effects compared to oral NSAIDs 1, 2, 4
  • Targeted delivery: Preferential distribution to target tissues in sufficient concentrations to produce therapeutic effect 4
  • Comparable efficacy: Studies show topical NSAIDs can provide similar pain relief to oral NSAIDs but with better tolerability 5, 4
  • Reduced GI risk: Lower rate of gastrointestinal complications than oral NSAIDs 4

Specific Recommendations

  1. First choice: Topical diclofenac gel has the strongest evidence for efficacy and safety 1, 2, 3
  2. Alternative options:
    • Ketoprofen gel (good efficacy but less available in some markets) 3
    • Ibuprofen gel (moderate efficacy) 3

Clinical Considerations

  • Best for: Localized pain in a limited number of joints 1
  • Application frequency: Apply 3-4 times daily to affected area 6
  • Duration of use: Can be used for both short-term (acute conditions) and long-term management (chronic conditions like osteoarthritis) 7
  • Limitations: When many joints are affected, systemic treatment may be preferred 1

Potential Adverse Effects

  • Local reactions: Generally mild and transient, including:

    • Dryness (22%)
    • Exfoliation (7%)
    • Erythema (4%)
    • Pruritus (2%) 6
  • Systemic adverse events: Rare and comparable to placebo 3, 7

Special Populations

  • Elderly patients: Particularly suitable for older adults due to reduced risk of systemic adverse effects 1, 2
  • Patients with comorbidities: Safe in patients with hypertension, type 2 diabetes, or cardiovascular disease 1

Important Caveats

  • Topical NSAIDs may be less effective for deep tissue pain such as low back pain 8
  • For acute low back pain, oral ibuprofen has shown better efficacy than topical diclofenac 8
  • No long-term data are available on the effects of topical NSAIDs beyond 12 weeks 1, 7
  • Response rates vary; approximately 60% of patients achieve significant pain reduction with topical diclofenac or ketoprofen 7

By selecting topical diclofenac gel as first-line therapy for localized musculoskeletal pain, clinicians can provide effective pain relief while minimizing systemic adverse effects, particularly in elderly patients or those with comorbidities that increase the risk of NSAID-related complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Knee Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical NSAIDs for acute musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2015

Research

Topical agents in the treatment of rheumatic pain.

Rheumatic diseases clinics of North America, 2008

Research

Topical NSAIDs for chronic musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.